Home>
US Stocks>
Neurocrine Biosciences

Neurocrine Biosciences share price today

(NBIX)

Neurocrine Biosciences share price is $135.42 & ₹11,507.45 as on 21 Dec 2024, 2.30 'hrs' IST

$135.42

▲

0.46

(0.34%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Neurocrine Biosciences share price in Dollar and Rupees. Guide to invest in Neurocrine Biosciences from India. Also see the sentimental analysis on Indian investors investing in Neurocrine Biosciences. Get details on the Indian mutual funds that are investing in Neurocrine Biosciences. Get Analyst recommendations and forecasts along with all the Neurocrine Biosciences's financials.

Neurocrine Biosciences share price movements

Today's Low: $134.36
Today's High: $137.01
$135.42
0.79%
Downside
Day's Volatility :1.94%
Upside
1.16%
52 Weeks Low: $110.95
52 Weeks High: $157.98
$135.42
18.07%
Downside
52 Weeks Volatility :29.77%
Upside
14.28%

Neurocrine Biosciences Returns

Period	Neurocrine Biosciences Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	14.62%	-12.2%	0.0%
6 Months	1.0%	-6.9%	0.0%
1 Year	5.07%	2.7%	0.0%
3 Years	58.94%	-0.2%	-17.3%

Neurocrine Biosciences Key Statistics

in dollars & INR

Previous Close	$134.96
Open	$134.98
Today's High	$137.01
Today's Low	$134.355
Market Capitalization	$13.7B
Today's Volume	$950.5K
52 Week High	$157.9799
52 Week Low	$110.95
Revenue TTM	$2.2B
EBITDA	$628.0M
Earnings Per Share (EPS)	$3.75
PE Ratio	35.99
Profit Margin	17.21%
Quarterly Earnings Growth YOY	0.51%
Return On Equity TTM	16.35%

How to invest in Neurocrine Biosciences from India?

It is very easy for Indian residents to invest directly in Neurocrine Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neurocrine Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neurocrine Biosciences or NBIX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neurocrine Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neurocrine Biosciences shares which would translate to 0.006 fractional shares of Neurocrine Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Neurocrine Biosciences, in just a few clicks!

Returns in Neurocrine Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Neurocrine Biosciences investment value today

Current value as on today

₹1,07,522

Returns

₹7,522

(+7.52%)

Returns from Neurocrine Biosciences Stock

₹5,426 (+5.43%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Neurocrine Biosciences

-9%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Neurocrine Biosciences on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -9% less investors are searching Neurocrine Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Neurocrine Biosciences

BlackRock Inc
14.02%
Vanguard Group Inc
9.87%
State Street Corp
5.08%
Renaissance Technologies Corp
2.54%
Bellevue Group AG
1.84%
Geode Capital Management, LLC
1.84%

Analyst Recommendation on Neurocrine Biosciences

Buy

76%Buy

23%Hold

0%Sell

Based on 34 Wall street analysts offering stock ratings for Neurocrine Biosciences(by analysts ranked 0 to 5 stars)

Based on 34 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Neurocrine Biosciences

What analysts predicted

Upside of 20.88%

Current:

$135.42

Target:

$163.69

Insights on Neurocrine Biosciences

Price Movement
In the last 7 days, NBIX stock has moved up by 6.5%
Increasing Revenue
Revenue is up for the last 11 quarters, 310.6M → 622.1M (in $), with an average increase of 6.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, 43.4M → 129.8M (in $), with an average increase of 41.6% per quarter
NBIX vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 19.9% return, outperforming this stock by 7.7%
Price to Sales
ForNBIX every $1 of sales, investors are willing to pay $6.0, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Neurocrine Biosciences Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$451.2M	↑ 179.19%
Net Income	$21.1M	↓ 114.81%
Net Profit Margin	4.68%	↑ 92.87%

	FY19	Y/Y Change
Revenue	$788.1M	↑ 74.65%
Net Income	$37.0M	↑ 75.26%
Net Profit Margin	4.69%	↑ 0.01%

	FY20	Y/Y Change
Revenue	$1.0B	↑ 32.71%
Net Income	$407.3M	↑ 1000.81%
Net Profit Margin	38.94%	↑ 34.25%

	FY21	Y/Y Change
Revenue	$1.1B	↑ 8.38%
Net Income	$89.6M	↓ 78.0%
Net Profit Margin	7.9%	↓ 31.04%

	FY22	Y/Y Change
Revenue	$1.5B	↑ 31.34%
Net Income	$154.5M	↑ 72.43%
Net Profit Margin	10.38%	↑ 2.48%

	FY23	Y/Y Change
Revenue	$1.9B	↑ 26.76%
Net Income	$249.7M	↑ 61.62%
Net Profit Margin	13.23%	↑ 2.85%

	Q2 FY23	Q/Q Change
Revenue	$452.7M	↑ 7.68%
Net Income	$95.5M	↓ 224.67%
Net Profit Margin	21.1%	↑ 39.32%

	Q3 FY23	Q/Q Change
Revenue	$498.8M	↑ 10.18%
Net Income	$83.1M	↓ 12.98%
Net Profit Margin	16.66%	↓ 4.44%

	Q4 FY23	Q/Q Change
Revenue	$515.2M	↑ 3.29%
Net Income	$147.7M	↑ 77.74%
Net Profit Margin	28.67%	↑ 12.01%

	Q1 FY24	Q/Q Change
Revenue	$515.3M	↑ 0.02%
Net Income	$43.4M	↓ 70.62%
Net Profit Margin	8.42%	↓ 20.25%

	Q2 FY24	Q/Q Change
Revenue	$590.2M	↑ 14.54%
Net Income	$65.0M	↑ 49.77%
Net Profit Margin	11.01%	↑ 2.59%

	Q3 FY24	Q/Q Change
Revenue	$622.1M	↑ 5.4%
Net Income	$129.8M	↑ 99.69%
Net Profit Margin	20.86%	↑ 9.85%

	FY18	Y/Y Change
Profit	$446.4M	↑ 178.32%

	FY19	Y/Y Change
Profit	$780.7M	↑ 74.91%

	FY20	Y/Y Change
Profit	$1.0B	↑ 32.68%

	FY21	Y/Y Change
Profit	$1.1B	↑ 8.05%

	FY22	Y/Y Change
Profit	$1.5B	↑ 30.94%

	FY23	Y/Y Change
Profit	$1.8B	↑ 26.06%

	Q2 FY23	Q/Q Change
Profit	$441.2M	↑ 7.11%

	Q3 FY23	Q/Q Change
Profit	$487.6M	↑ 10.52%

	Q4 FY23	Q/Q Change
Profit	$506.7M	↑ 3.92%

	Q1 FY24	Q/Q Change
Profit	$502.5M	↓ 0.83%

	Q2 FY24	Q/Q Change
Profit	$574.6M	↑ 14.35%

	Q3 FY24	Q/Q Change
Profit	$614.1M	↑ 6.87%

	FY18	Y/Y Change
Operating Cash Flow	$101.4M	↓ 207.46%
Investing Cash Flow	$-242.9M	↓ 3.17%
Financing Cash Flow	$29.5M	↓ 94.28%

	FY19	Y/Y Change
Operating Cash Flow	$152.1M	↑ 50.01%
Investing Cash Flow	$-211.1M	↓ 13.11%
Financing Cash Flow	$27.3M	↓ 7.51%

	FY20	Y/Y Change
Operating Cash Flow	$228.5M	↑ 50.28%
Investing Cash Flow	$4.1M	↓ 101.94%
Financing Cash Flow	$-157.8M	↓ 677.75%

	FY21	Y/Y Change
Operating Cash Flow	$256.5M	↑ 12.25%
Investing Cash Flow	$-130.2M	↓ 3275.61%
Financing Cash Flow	$27.4M	↓ 117.36%

	FY22	Y/Y Change
Operating Cash Flow	$339.4M	↑ 32.32%
Investing Cash Flow	$-177.1M	↑ 36.02%
Financing Cash Flow	$-234.3M	↓ 955.11%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$179.6M	↓ 243.45%
Investing Cash Flow	$-125.9M	↑ 199.05%
Financing Cash Flow	$2.9M	↓ 64.63%

Neurocrine Biosciences Technicals Summary

Sell

Neutral

Buy

Neurocrine Biosciences is currently in a neutral trading position according to technical analysis indicators.

Neurocrine Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Neurocrine Biosciences Inc.	9.47%	1.0%	5.07%	58.94%	24.49%
Haleon Plc Spon Ads	2.32%	12.27%	19.02%	30.9%	30.9%
Zoetis Inc.	-6.92%	-4.84%	-16.13%	-32.31%	23.53%
Viatris Inc.	-7.62%	15.85%	13.9%	-8.45%	-25.76%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.56	28.56	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	31.33	31.33	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Neurocrine Biosciences Inc.	Buy	$13.7B	24.49%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.2B	30.9%	28.56	10.75%
Zoetis Inc.	Buy	$75.3B	23.53%	31.33	26.55%
Viatris Inc.	Hold	$14.6B	-25.76%	224.4	-5.87%

About Neurocrine Biosciences

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

Organization	Neurocrine Biosciences
Employees	1700
CEO	Mr. Kyle W. Gano Ph.D.
Industry	Health Technology

Management People of Neurocrine Biosciences

Name	Title
Mr. Kyle W. Gano Ph.D.	CEO & Director
Mr. Matthew C. Abernethy CPA	Chief Financial Officer
Dr. Jude Onyia Ph.D.	Chief Scientific Officer
Dr. Eiry Wyn Roberts M.D.	Chief Medical Officer
Dr. Lawrence Steinman BA, M.D., Ph.D.	Co-Founder of Neurocrine
Jane Sorensen	Head of Investor Relations
Mr. Darin M. Lippoldt Esq.	Chief Legal Officer & Corporate Secretary
Ms. Julie S. Cooke	Chief Human Resources Officer
Mr. Eric S. Benevich	Chief Commercial Officer
Mr. David Warren Boyer	Chief Corporate Affairs Officer

Important FAQs about investing in Neurocrine Biosciences from India :

What is Neurocrine Biosciences share price today?

Neurocrine Biosciences share price today stands at $135.42, Open: $134.98 ; Previous Close: $134.96 ; High: $137.01 ; Low: $134.36 ; 52 Week High: $157.98 ; 52 Week Low: $110.95. The stock opens at $134.98, after a previous close of $134.96. The stock reached a daily high of $137.01 and a low of $134.36, with a 52-week high of $157.98 and a 52-week low of $110.95.

Can Indians buy Neurocrine Biosciences shares?

Yes, Indians can invest in the Neurocrine Biosciences (NBIX) from India.

With INDmoney, you can buy Neurocrine Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Neurocrine Biosciences at zero transaction cost.

How can I buy Neurocrine Biosciences shares from India?

It is very easy to buy Neurocrine Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neurocrine Biosciences be purchased?

Yes, you can buy fractional shares of Neurocrine Biosciences with INDmoney app.

What are the documents required to start investing in Neurocrine Biosciences stocks?

To start investing in Neurocrine Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.